Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 51 Article 6
Back to Table of Contents
Previous
Next

Eurosurveillance, Volume 7, Issue 51, 18 December 2003
Articles

Citation style for this article: de Neeling AJ, Wannet WJ. Study shows low rate of transmission of MRSA in Dutch nursing homes. Euro Surveill. 2003;7(51):pii=2349. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2349

Study shows low rate of transmission of MRSA in Dutch nursing homes

Han de Neeling (Han.de.Neeling@rivm.nl) and Wim Wannet, Laboratory for Infectious Diseases and Perinatal Screening, National Institute of Public Health and the Environment, the Netherlands.

A systematic study was undertaken from 2000 to 2002 to determine the occurrence of methicillin resistant Staphylococcus aureus (MRSA) in nursing homes in four regions of the Netherlands (1), including Amsterdam, which was also investigated 10 years ago (2). The three other regions were selected for the study because prior to this, MRSA had emerged in local hospitals and nursing homes. The study included 16 nursing homes in total. All participants in the study were tested by obtaining a nasal swab, and, where possible, a wound swab. Eight of the 1218 residents tested (0.7%) were found to be carrying MRSA (1). As shown by pulsed field gel electrophoresis (PFGE), the MRSA isolates were indistinguishable from each other and to MRSA from local hospitals. Indistinguishable strains were assumed to have arisen from the same source, or by cross infection.Therefore MRSA may have been transmitted from local hospitals to nursing homes through transfer of patients or vice versa.

This low prevalence of MRSA carriage, even though this carriage can last for months or years, indicates a very low rate of transmission.The prevalence of 0.7% MRSA in these Dutch nursing homes was higher than the prevalence of 0.2% found in a similar survey in the Netherlands carried out 10 years ago in nursing homes in Amsterdam and Rotterdam (2), but lower than the prevalence of 4.9% in Belgian nursing homes (5). In studies of German nursing homes (3,4), a prevalence of 1.1-2.4% was found, although in the first study (3), 30 of the 36 MRSA cases detected were of the same strain, probably picked up from a nearby hospital. So the transmission of MRSA in German nursing homes also appears to be low. Although this study observed a higher prevalence in the Dutch nursing homes than the previous Dutch study, it should be borne in mind that this percentage is still low and that the homes participating in the study had had elevated levels of MRSA incidence in the past, or received patients from hospitals with MRSA outbreaks.

This conclusion is in line with the relatively low prevalence of MRSA in Dutch hospitals in comparison with the surrounding countries (see website of European Antimicrobial Resistance Surveillance System (EARSS), http://www.earss.rivm.nl/).The low prevalence may be due to the relatively restrained use of antibiotics in the Netherlands compared with other European countries (see website of European Surveillance of Antimicrobial Consumption (ESAC), http://www.ua.ac.be/main.asp?c=*ESAC) and the adherence to strict infection control guidelines as issued by the Werkgroep Infectie Preventie (WIP, Dutch working party on infection prevention, guidelines available at http://www.wip.nl/).

References:
  1. De Neeling AJ, Wagenvoort JHT, Leenders ACAP, Peerbooms PGH, Hendrix MGR, Wannet WJB. Het vóórkomen van MRSA bij verpleeghuispatiënten. Infectieziektenbulletin 2003; 14: 394-8. (http://www.rivm.nl/infectieziektenbulletin/bul1411/art_voorkomen.html)
  2. Frénay HME, Peerbooms PGH, van Leeuwen WJ, Wynne HJA, Verhoef J, Hendriks WDH, et al. Nursing homes: not a source of methicillin resistant Staphylococcus aureus in the Netherlands. Clin Infect Dis 1994; 19: 213-5
  3. Von Baum H, Schmidt C, Svoboda D, Bock-Hensley O, Wendt C. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infect Control Hosp Epidemiol 2002; 23: 511-5
  4. Heuck D, Fell G, Hamouda O, Claus H, Witte W. Erste Ergebnisse einer überregionalen Studie zur MRSA-besiedlung bei Bewohnern von Alten- und Pflegeheimen. Hyg Med 2000; 25: 191-2.
  5. Hoefnagels-Schuermans A, Niclaes L, Buntinx F, Suetens C, Jans B, Verhaegen J, Van Eldere J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in nursing homes: a cross-sectional study. Infect Control Hosp Epidemiol 2002; 23:546-9

back to top



Back to Table of Contents
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.